Changes in the composition of Innate Pharma's Supervisory Board | Innate Pharma

Tue, 05/22/2007 - 18:28

Innate Pharma S.A. announced changes in the composition of its Supervisory Board.

PR in english	37.15 KB
CP en français	38.41 KB

Company
Science
Products
- Pipeline overview
- ------------------
- Lacutamab
- IPH4502
- Monalizumab
- Other Clinical Stage Assets
  - IPH6501
  - IPH6101
  - IPH6401
  - IPH5201
  - IPH5301
Partnering
Investors
Media
Careers